| Kandice Mcalpine, PA-C | |
|
4201 Aero Dr, Mason, OH 45040-8818 | |
| (513) 770-4122 | |
| Not Available |
| Full Name | Kandice Mcalpine |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 4 Years |
| Location | 4201 Aero Dr, Mason, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437812500 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080A0000X | Pediatrics - Adolescent Medicine | 4749 (Tennessee) | Secondary |
| 363A00000X | Physician Assistant | 50.006953RX (Ohio) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mid Valley Gastorenterology Associates, Inc. | 5092748921 | 3 |
News Archive
A new international study has made an important discovery about the key role of macrophages, a type of immune cell, in systemic sclerosis (SSc), a chronic autoimmune disease which currently has no cure.
GE Healthcare has successfully linked its electronic medical records (EMR) solution with several non-GE inpatient systems, providing a single view of the patient record that will go beyond the requirements of meaningful use. The interoperability solution is set to debut at beta sites Capital Region Healthcare (N.H.) and Decatur Memorial Hospital (Ill.) in early 2011 with general availability expected later that year.
CardioVascular BioTherapeutics, Inc. today announced it has submitted an application to the U.S. FDA to obtain "fast track" designation for CVBT-141B, its biological therapy to treat ischemic diabetic wounds based on the active ingredient fibroblast growth factor-1 (FGF-1).
The WHO's Stop TB Department released data on Thursday at the 40th Union World Conference on Lung Health indicating that the number of new active TB cases worldwide rose from 9.27 million in 2007 to 9.4 million in 2008, Reuters reports. Experts, who were gathered for the conference in Cancun, Mexico, "called for more research funding to develop better diagnostic tests, vaccines and drugs for tuberculosis, which killed 1.8 million people around the world last year," according to the news service.
Patients with rheumatoid arthritis (RA) who initiated use of anti-tumor necrosis factor therapies were not at a higher risk of developing herpes zoster (shingles), compared with patients who initiated nonbiologic treatment regimens, according to research from the University of Alabama at Birmingham (UAB) and the Oregon Health and Science University. The findings appeared in the March 6, 2013, issue of the Journal of the American Medical Association (JAMA).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kandice Mcalpine, PA-C 3992 Crestview Dr, Loveland, OH 45140-1019 Ph: (513) 939-5353 | Kandice Mcalpine, PA-C 4201 Aero Dr, Mason, OH 45040-8818 Ph: (513) 770-4122 |
News Archive
A new international study has made an important discovery about the key role of macrophages, a type of immune cell, in systemic sclerosis (SSc), a chronic autoimmune disease which currently has no cure.
GE Healthcare has successfully linked its electronic medical records (EMR) solution with several non-GE inpatient systems, providing a single view of the patient record that will go beyond the requirements of meaningful use. The interoperability solution is set to debut at beta sites Capital Region Healthcare (N.H.) and Decatur Memorial Hospital (Ill.) in early 2011 with general availability expected later that year.
CardioVascular BioTherapeutics, Inc. today announced it has submitted an application to the U.S. FDA to obtain "fast track" designation for CVBT-141B, its biological therapy to treat ischemic diabetic wounds based on the active ingredient fibroblast growth factor-1 (FGF-1).
The WHO's Stop TB Department released data on Thursday at the 40th Union World Conference on Lung Health indicating that the number of new active TB cases worldwide rose from 9.27 million in 2007 to 9.4 million in 2008, Reuters reports. Experts, who were gathered for the conference in Cancun, Mexico, "called for more research funding to develop better diagnostic tests, vaccines and drugs for tuberculosis, which killed 1.8 million people around the world last year," according to the news service.
Patients with rheumatoid arthritis (RA) who initiated use of anti-tumor necrosis factor therapies were not at a higher risk of developing herpes zoster (shingles), compared with patients who initiated nonbiologic treatment regimens, according to research from the University of Alabama at Birmingham (UAB) and the Oregon Health and Science University. The findings appeared in the March 6, 2013, issue of the Journal of the American Medical Association (JAMA).
› Verified 9 days ago